Complementary and Alternative Therapy Use in Children with Cerebral Palsy.


Journal

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
ISSN: 0317-1671
Titre abrégé: Can J Neurol Sci
Pays: England
ID NLM: 0415227

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 29 8 2020
medline: 30 9 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

To describe complementary and alternative medicine (CAM) use amongst children with cerebral palsy (CP) in Canada and to identify factors associated with CAM use. We conducted a cross-sectional study, utilising data from the Canadian CP Registry. We explored the association between CAM use and regional, socioeconomic and CP phenotypic variables, and parental perception of the family-centredness of clinical care using the Measures of Process of Care-56 (MPOC-56). Chi-square analyses were performed, and odds ratios (OR) and 95% confidence intervals (CI) were obtained. Mann-Whitney U tests were used to compare MPOC-56 scores between CAM users and non-CAM users. The study sample consisted of 313 families of which 27% reported CAM use in the past year. Children with CP using CAM were more likely to reside in Western Canada (OR 3.3, 95% CI 1.6-6.7), live in a two-parent household (OR 3.5, 95% CI 1.5-8.4), have an ataxic/hypotonic or dyskinetic CP subtype (OR 3.0, 95% CI 1.5-6.1) and have a greater motor impairment (OR 2.8, 95% CI 1.7-4.9). MPOC-56 subscale scores were not significantly associated with CAM use. Physicians need to be aware of existing CAM therapies, the level of evidence supporting their efficacy (beneficence), their associated risks of adverse events (non-maleficence) and enable fair access to care that may be of benefit to each child.

Identifiants

pubmed: 32854793
pii: S0317167120001882
doi: 10.1017/cjn.2020.188
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-414

Auteurs

Maryam Oskoui (M)

Department of Pediatrics, McGill University, Montreal, QC, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Pamela Ng (P)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Michele Zaman (M)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.

David Buckley (D)

Janeway Children's Hospital, St. John's, NL, Canada.

Adam Kirton (A)

Departments of Pediatrics and Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Esias van Rensburg (E)

BC Children's Hospital, Vancouver, BC, Canada.

Ellen Wood (E)

IWK Health Centre, Halifax, NS, Canada.

Michael Shevell (M)

Department of Pediatrics, McGill University, Montreal, QC, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Annette Majnemer (A)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH